The content of this website is intended for healthcare professionals only

Planned intermittent fasting may help treat type 2 diabetes

Need for insulin dropped in the case studies shown

Jo Carlowe

Wednesday, 10 October 2018

Planned intermittent fasting may help to reverse type 2 diabetes, new research shows.

In an article* in the journal BMJ Case Reports, doctors describe how three patients in their care, were able to cut out the need for insulin treatment, following planned intermittent fasting.

The paper describes how three men, aged between 40 and 67, tried out planned intermittent fasting to see if it might ease their symptoms. They were taking various drugs to control their disease as well as daily units of insulin. In addition to type 2 diabetes, they all had high blood pressure and high cholesterol.

Two of the men fasted on alternate days for a full 24 hours, while the third fasted for three days a week. On fast days they were allowed to drink very low-calorie drinks, such as tea/coffee, water or broth, and to eat one very low-calorie meal in the evening.

Before embarking on their fasting regime, they all attended a six-hour long nutritional training seminar, which included information on how diabetes develops and its impact on the body; insulin resistance; healthy eating; and how to manage diabetes through diet, including therapeutic fasting.

They stuck to this pattern for around 10 months after which fasting blood glucose, average blood glucose (HbA1c), weight, and waist circumference were re-measured.

All three men were able to stop injecting themselves with insulin within a month of starting their fasting schedule. In one case this took only five days.

Two of the men were able to stop taking all their other diabetic drugs, while the third discontinued three out of the four drugs he was taking. They all lost weight (by 10-18%) as well as reducing their fasting and average blood glucose readings, which may help lower the risk of future complications, say the authors.

Feedback was positive, with all three men managing to stick to their dietary schedule without too much difficulty.

This is an observational study, and refers to just three cases. As such, it isn’t possible to draw firm conclusions about the wider success or otherwise of this approach for treating type 2 diabetes.

“The use of a therapeutic fasting regimen for treatment of [type 2 diabetes] is virtually unheard of,” write the authors.

“This present case series showed that 24-hour fasting regimens can significantly reverse or eliminate the need for diabetic medication,” they conclude.

*Furmli S, Elmasry R, Ramos M, et al. Therapeutic use of intermittent fasting for people with type 2 diabetes as an alternative to insulin. BMJ Case Reports 2018; doi:10.1136/bcr-2017-221854

21646-Regional-Networks-Email-Footer v2.jpg

Free to attend for NHS and associated professionals, attendees benefit from:

  • Network with like-minded colleagues in your discipline and relevant stakeholders  
  • High quality local discussions with relevant peers on the event day stimulated by speakers sharing best practice case studies 
  • Hear from expert speakers in your therapy area including regulators such as NICE on key topics and care pathways
  • Earn 3+ hours of CPD accredited activity for attending

 Upcoming meeting

East Midlands Diabetes Mellitus Network 13 November
Yew Lodge Kegworth,
Chaired by Professor Ian Macdonald – Professor of Metabolic Physiology, University of Nottingham

For further information please visit our HSJ Regional Networks website or get in touch with the team at networkevents@wilmingtonhealthcare.com.

Registered in England and Wales. Reg No. 2530185. c/o Wilmington plc, 5th Floor, 10 Whitechapel High Street, London E1 8QS. Reg No. 30158470